Literature DB >> 21952950

Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer.

Stijn Keereweer1, Isabel M Mol, Jeroen D F Kerrebijn, Pieter B A A Van Driel, Bangwen Xie, Robert J Baatenburg de Jong, Alexander L Vahrmeijer, Clemens W G M Löwik.   

Abstract

BACKGROUND AND OBJECTIVES: Near-infrared (NIR) fluorescence optical imaging is a promising technique to assess the tumor margins during cancer surgery. This technique requires targeting by specific fluorescence agents to differentiate tumor from normal surrounding tissue. We assessed the feasibility of cancer detection using NIR fluorescence agents that target either αvβ3 integrins or the enhanced permeability and retention (EPR) effect in an orthotopic mouse model of oral cancer.
METHODS: Binding of the integrin-targeted agent to tumor cells was assessed in vitro. Oral cancer was induced in 6 BALB/c nu/nu mice by submucosal inoculation of human OSC19-luc cells into the tongue. Tumor growth was followed with bioluminescence imaging. A combination of agents targeting integrins or EPR effect was injected followed by fluorescence imaging in vivo and ex vivo after resection of the tongues.
RESULTS: Oral cancer was clearly demarcated in vitro; in vivo; and on histological analysis with sufficient tumor-to-background ratios of the contrast agents.
CONCLUSION: This study demonstrates the feasibility of optical imaging of oral squamous cell carcinoma based on targeting of αvβ3 integrins and the EPR effect. Once these NIR fluorescence agents become available for clinical testing, optical image-guided surgery could reduce residual disease after oral cancer surgery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952950     DOI: 10.1002/jso.22102

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  16 in total

1.  A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.

Authors:  Mingzhen Zhang; Changlong Xu; Liuqing Wen; Moon Kwon Han; Bo Xiao; Jun Zhou; Yuchen Zhang; Zhan Zhang; Emilie Viennois; Didier Merlin
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

2.  Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.

Authors:  Martin C Boonstra; Berend Tolner; Boudewijn E Schaafsma; Leonora S F Boogerd; Hendrica A J M Prevoo; Guarav Bhavsar; Peter J K Kuppen; Cornelis F M Sier; Bert A Bonsing; John V Frangioni; Cornelis J H van de Velde; Kerry A Chester; Alexander L Vahrmeijer
Journal:  Int J Cancer       Date:  2015-06-22       Impact factor: 7.396

Review 3.  Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans.

Authors:  Ihab Atallah; Clément Milet; Jean-Luc Coll; Emile Reyt; Christian Adrien Righini; Amandine Hurbin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-13       Impact factor: 2.503

4.  Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.

Authors:  Kristine E Day; Larissa Sweeny; Brian Kulbersh; Kurt R Zinn; Eben L Rosenthal
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

5.  Near-infrared fluorescence imaging of both colorectal cancer and ureters using a low-dose integrin targeted probe.

Authors:  Floris P R Verbeek; Joost R van der Vorst; Quirijn R J G Tummers; Martin C Boonstra; Karien E de Rooij; Clemens W G M Löwik; A Rob P M Valentijn; Cornelis J H van de Velde; Hak Soo Choi; John V Frangioni; Alexander L Vahrmeijer
Journal:  Ann Surg Oncol       Date:  2014-02-11       Impact factor: 5.344

Review 6.  Shifting focus in optical image-guided cancer therapy.

Authors:  Stijn Keereweer; Pieter B A A Van Driel; Dominic J Robinson; Clemens W G M Lowik
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

7.  Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.

Authors:  P B A A van Driel; J R van der Vorst; F P R Verbeek; S Oliveira; T J A Snoeks; S Keereweer; B Chan; M C Boonstra; J V Frangioni; P M P van Bergen en Henegouwen; A L Vahrmeijer; C W G M Lowik
Journal:  Int J Cancer       Date:  2013-12-12       Impact factor: 7.396

Review 8.  Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery.

Authors:  Hakan Orbay; Jero Bean; Yin Zhang; Weibo Cai
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

Review 9.  Nanomedicine: a primer for surgeons.

Authors:  K K Y Wong; X L Liu
Journal:  Pediatr Surg Int       Date:  2012-08-15       Impact factor: 1.827

10.  uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.

Authors:  Martin C Boonstra; Pieter B A A van Driel; Danny M van Willigen; Marieke A Stammes; Hendrica A J M Prevoo; Quirijn R J G Tummers; Andrew P Mazar; Freek J Beekman; Peter J K Kuppen; Cornelis J H van de Velde; Clemens W G M Löwik; John V Frangioni; Fijs W B van Leeuwen; Cornelis F M Sier; Alexander L Vahrmeijer
Journal:  Oncotarget       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.